期刊文献+

Use of butyrate or glutamine in enema solution reduces inflammation and fibrosis in experimental diversion colitis 被引量:9

Use of butyrate or glutamine in enema solution reduces inflammation and fibrosis in experimental diversion colitis
在线阅读 下载PDF
导出
摘要 AIM:To investigate whether butyrate or glutamine enemas could diminish inflammation in experimental diversion colitis.METHODS:Wistar specific pathogen-free rats were submitted to a Hartmann's end colostomy and treated with enemas containing glutamine,butyrate,or saline.Enemas were administered twice a week in the excluded segment of the colon from 4 to 12 wk after the surgical procedure.Follow-up colonoscopy was performed every 4 wk for 12 wk.The effect of treatment was evaluated using video-endoscopic and histologic scores and measuring interleukin-1β,tumor necrosis factor-alpha,and transforming growth factor beta production in organ cultures by enzyme linked immunosorbent assay.RESULTS:Colonoscopies of the diverted segment showed mucosa with hyperemia,increased number of vessels,bleeding and mucus discharge.Treatment with either glutamine or butyrate induced significant reductions in both colonoscopic(P < 0.02) and histological scores(P < 0.01) and restored the densities of collagen fibers in tissue(P = 0.015;P = 0.001),the number of goblet cells(P = 0.021;P = 0.029),and the rate of apoptosis within the epithelium(P = 0.043;P = 0.011) to normal values.The high levels of cytokines in colon explants from rats with diversion colitis significantly decreased to normal values after treatment with butyrate or glutamine.CONCLUSION:The improvement of experimental diversion colitis following glutamine or butyrate enemas highlights the importance of specific luminal nutrients in the homeostasis of the colonic mucosa and supports their utilization for the treatment of human diversion colitis. AIM:To investigate whether butyrate or glutamine enemas could diminish inflammation in experimental diversion colitis.METHODS:Wistar specific pathogen-free rats were submitted to a Hartmann's end colostomy and treated with enemas containing glutamine,butyrate,or saline.Enemas were administered twice a week in the excluded segment of the colon from 4 to 12 wk after the surgical procedure.Follow-up colonoscopy was performed every 4 wk for 12 wk.The effect of treatment was evaluated using video-endoscopic and histologic scores and measuring interleukin-1β,tumor necrosis factor-alpha,and transforming growth factor beta production in organ cultures by enzyme linked immunosorbent assay.RESULTS:Colonoscopies of the diverted segment showed mucosa with hyperemia,increased number of vessels,bleeding and mucus discharge.Treatment with either glutamine or butyrate induced significant reductions in both colonoscopic(P 〈 0.02) and histological scores(P 〈 0.01) and restored the densities of collagen fibers in tissue(P = 0.015;P = 0.001),the number of goblet cells(P = 0.021;P = 0.029),and the rate of apoptosis within the epithelium(P = 0.043;P = 0.011) to normal values.The high levels of cytokines in colon explants from rats with diversion colitis significantly decreased to normal values after treatment with butyrate or glutamine.CONCLUSION:The improvement of experimental diversion colitis following glutamine or butyrate enemas highlights the importance of specific luminal nutrients in the homeostasis of the colonic mucosa and supports their utilization for the treatment of human diversion colitis.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第32期4278-4287,共10页 世界胃肠病学杂志(英文版)
基金 Supported by Grants from the Brazilian Research Council Fundao de Amparo à Pesquisa do Estado do Rio de Janeiro
关键词 Diversion colitis Butyrate Glutamine Shortchain fatty acids Cytokines 结肠炎 丁酸 引水 实验 炎症 酶联免疫吸附试验 纤维化 谷氨酸
作者简介 Correspondence to: Heitor Siffert P de Souza, MD, PhD, Department of Internal Medicine, Hospital Universitario Clementino Fraga Filho, Federal University of Rio de Janeiro, Rua Prof. Rodolpho Paulo Rocco 255, Ilha do Fundao, Rio de Janeiro, RJ 21941-913, Brazil. heitor.souza@gmail.eom Telephone: +55-21-25622669 Fax: +55-21-25622669
  • 相关文献

参考文献1

二级参考文献25

  • 1[1]Cummings JH.Short chain fatty acids in the human colon.Gut 1981;22:763-779
  • 2[2]Roediger WE,Nance S.Metabolic induction of experimental ulcerative colitis by inhibition of fatty acid oxidation.Br J Exp Pathol 1986:67:773-782
  • 3[3]Chapman MA,Grahn MF,Boyle MA,Hutton M,Rogers J,Williams NS.Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis.Gut 1994;35:73-76
  • 4[4]Chapman MA,Grahn MF,Hutton M,Williams NS.Butyrate metabolism in the terminal ileal mucosa of patients with ulcerative colitis.Br J Surg 1995;82:36-38
  • 5[5]Finnie IA,Taylor BA,Rhodes JM.Ileal and colonic epithelial metabolism in quiescent ulcerative colitis:increased glutamine metabolism in distal colon but no defect in butyrate metabolism.Gut 1993;34:1552-1558
  • 6[6]Scheppach W,Sommer H,Kirchner T,Paganelli GM,Bartram P,Christl S,Richter F,Dusel G,Kasper H.Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis.Gastroenterology 1992;103:51-56
  • 7[7]Steinhart AH,Hiruki T,Brzezinski A,Baker JP.Treatment of left-sided ulcerative colitis with butyrate enemas:a controlled trial.Aliment Pharmacol Ther 1996;10:729-736
  • 8[8]Patz J,Jacobsohn WZ,Gottschalk-Sabag S,Zeides S,Braverman DZ,Treatment of refractory distal ulcerative colitis with short chain fatry acid enemas,Am J Gastroenterol 1996;91:731-734
  • 9[9]Scheppach W.Treatment of distal ulcerative colitis with shortchain fatty acid enemas.A placebo-controlled trial.German-Austrian SCFA Study Group.Dig Dis Sci 1996;41:2254-2259
  • 10[10]Den Hond E,Hiele M,Evenepoel P,Peeters M,Ghoos Y,Rutgeerts P,In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis.Gastroenterology 1998;115:584-590

共引文献8

同被引文献60

引证文献9

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部